Sinohealth Holdings (HKSE:02361) 3-Year EBITDA Growth Rate : -0.40% (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Sinohealth Holdings 3-Year EBITDA Growth Rate?

Sinohealth Holdings's EBITDA per Share for the six months ended in Dec. 2024 was HK$0.22.

During the past 12 months, Sinohealth Holdings's average EBITDA Per Share Growth Rate was 8.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -0.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sinohealth Holdings was 11.20% per year. The lowest was -1.70% per year. And the median was -0.40% per year.

Competitive Comparison of Sinohealth Holdings's 3-Year EBITDA Growth Rate

For the Health Information Services subindustry, Sinohealth Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinohealth Holdings's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sinohealth Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sinohealth Holdings's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Sinohealth Holdings 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Sinohealth Holdings (HKSE:02361) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Sinohealth Holdings 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sinohealth Holdings's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinohealth Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sinohealth Holdings Ltd (HKSE:02361) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5 Wangjiang Second Street, Room 1111, Huangge Town, Nansha District, Guangdong Province, Guangzhou City, CHN

Website

https://ir.sinohealth.cn

Sinohealth is a leading provider of Big Data and artificial intelligence-based marketing and distribution information tools, including SaaS-based customer relationship management solutions to mainland China medical product manufacturers. It sources retail data through pharmacy partnerships and provides data analysis to the pharmaceutical and corporate clients it serves. Since its establishment in 2007, its focus has been on building a strong Big Data engine and networking capabilities to assist clients in their product investments and sales and marketing strategies. It is now launching various cloud-based systems and platform solutions for its clients and expanding its SaaS products, which are expected to be the key growth driver in future.

Executives

Futu Trustee Limited	2301 Trustee
Shanghai Tianyi Assets Management Co., Ltd	2201 Interest of corporation controlled by you
Yu Rong	2201 Interest of corporation controlled by you
Tianyi (bvi) Limited	2101 Beneficial owner
Shang Hai Xuan Yu Qi Ye Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Rikan Industry Investment Limited Partnership
Wang Lifang	2201 Interest of corporation controlled by you
Wu Yushu	2201 Interest of corporation controlled by you
Wlf Investment Holdings Limited	2101 Beneficial owner
Li Hanxiong	2201 Interest of corporation controlled by you
Montesy Capital Holding Ltd	2101 Beneficial owner
Wu Meirong	2202 Interest of your spouse
Ying Lian You Xian Gong Si	2101 Beneficial owner

Sinohealth Holdings Headlines

No Headlines